Federico Croci

Postdoctoral researcher at @institutpasteur.
Chemoinformatics and computer-aided drug design.

[Ingo Hartung @HartungIngo]

It‘s time to remove the question mark!

A huge congrats to @CraigMCrews, Ray Deshaies and the scientists @ArvinasInc.

1st FDA approval for a #PROTAC on May 1st 2026. A day to remember. Extra drinks at the Proxidrugs GRC in a few weeks!

[nature @Nature]

For the first time, researchers have simulated nearly every chemical reaction in a living bacterial cell

https://t.co/iLgKka2QS5

[DAISY Lab-UNIPG @DaisyLabUNIPG]

We are very pleased to announce that this week Gabriele Cruciani was awarded with the Fujita Award from QSAR, Cheminformatics and Modelling Society (QCMS). Congrats, Gabry!

[Andy Murray @andy_murray]

Never even liked tennis anyway.

[Arvinas @ArvinasInc]

#NEWS: Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease

Read the full press release here: https://t.co/OGSuEV5XOW

[IRB Barcelona @IRBBarcelona]

💥Thank you to all the brilliant participants & attendees of our recent #BarcelonaBioMed Conference! 🙏 Your passion & dedication to advancing science through targeted protein degradation is truly inspiring!🎯✨

👉Special thanks to @FundacionBBVA for making it possible.

🗣️💡The exchange of knowledge & ideas during the past 3 days in #Barcelona has been invaluable in pushing the boundaries of this promising field😍

Thank you all!🙏

#TPD #ChemBio #WeAreIRB

[Chroma Festival @ChromaFestival]

🦎 #Chroma23🦎
1-2-3-4 GIUGNO
Umbriafiere - Bastia Umbra (PG)

🎫 Early Bird disponibili su https://t.co/TiwEyBBTcT

Artwork: @marticholas

[TommasoPalomba @TommasoPalomba6]

Glad to share our recent work "Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design".
https://t.co/iHMact90el #PROTAC #E3ligase #TRIM33
#mdpiijms
@IJMS_MDPI @UniperugiaNews @moldiscovery

[Federico Croci @effe_croci]

I’m so proud to finally share this paper that has just been published in @ChemBioChem 👏🏻 It tells about the work that I carried out during my #Erasmus period at @UvA_Amsterdam 🇳🇱 Thanks to all the co-authors, especially to @FG_Mutti and his group at @HimsUva 🫶🏻

[Francesco Mutti @FG_Mutti]

Biocatalytic Reductive Amination in Flow using Co-Entrapped Dehydrogenases and a 3D-Printed Mould Reactor is now #OpenAccess in @chembiochem
Thanks to co-authors @effe_croci, J Vilim, T Adamopoulou, @tseliouvas, @PMcShoe & T Knaus
@UvA_Amsterdam
@HimsUva
https://t.co/7NRWMV4reP

[Tom Morello @tmorello]

Congrats to my former ⁦@Harvard⁩ bandmate ⁦@CarolynBertozzi⁩ on her ⁦@NobelPrize⁩ in chemistry! We won the Ivy League Battle of the Bands in 1986 with our rockin’ group ‘Bored Of Education’, with her on keyboards & me in spandex. https://t.co/LemA6pcSPV

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”

[Patagonia @patagonia]

Hey, friends, we just gave our company to planet Earth. OK, it’s more nuanced than that, but we’re closed today to celebrate this new plan to save our one and only home. We’ll be back online tomorrow.
https://t.co/fvRFDgOzVZ

[DAISY Lab-UNIPG @DaisyLabUNIPG]

Very excited to share that Jenny Desantis @Jenny_Des was awarded with the prize "Premio Nicolò Vivona" for the best oral communication on the chemistry of heterocycles! Well done, Jenny! So proud of you!#CDCO2022 #PROTACs Thanks to @SCIorganica

[Federico Croci @effe_croci]

@MargaridaEspad1 @EuroMedChem @Roche @SantosMMM_MChem Congratulations! 👏

[DCF-SCI @DCFSCI]

We are back: 27th National Meeting on Medicinal Chemistry is starting #NMMC27 #medchem #medicinalchemistry

[Federico Croci @effe_croci]

@labmasc just opened #TUMA2022 ! Good meeting and good work to everyone joining.

@sci_umbria @UniperugiaNews

[Federico Croci @effe_croci]

@feders_z 🫶🏻

[Federico Croci @effe_croci]

Here is our recently published work! The study is focused on physochemical properties of #PROTACs, specifically those bearing piperazine-containing linkers, to help their rational design.
Cheers to all contrbutors 🍻

https://t.co/xyOQzkjuMJ

[Guillaume Laconde @Glaconde34]

ELIOT: A platform to navigate the E3 pocketome and aid the design of new PROTACs https://t.co/7mUwVKLMTD

[Federico Croci @effe_croci]

#SEQT_SummerSchool just finished today. Thanks to the organizing committee and all the participants for this wonderful experience!
@SocEspQuimTerap @EuroMedChem